Authors:
SCHLEMMER HP
DIETZ A
BECKER M
WOLLENSACK P
BACHERT P
RUDAT V
VANSELOW B
KNOPP M
WANNENMACHER M
WEIDAUER H
VANKAICK G
Citation: Hp. Schlemmer et al., MONITORING OF 5-FU PHARMACOKINETICS IN CERVICAL LYMPH-NODE METASTASESFROM HEAD AND NECK CARCINOMAS BY MEANS OF IN-VIVO 19F MR SPECTROSCOPY, British Journal of Cancer, 77, 1998, pp. 125-125
Authors:
SCHLEMMER HP
BACHERT P
SEMMLER W
HOHENBERGER P
SCHLAG P
LORENZ WJ
VANKAICK G
Citation: Hp. Schlemmer et al., DRUG-MONITORING OF 5-FLUOROURACIL - IN-VIVO F-19 NMR-STUDY DURING 5-FU CHEMOTHERAPY IN PATIENTS WITH METASTASES OF COLORECTAL ADENOCARCINOMA, Magnetic resonance imaging, 12(3), 1994, pp. 497-511
Authors:
SCHLEMMER HP
HESS T
DEBUS J
KNOPP MV
SCHAD LR
ENGENHART R
Citation: Hp. Schlemmer et al., TOF MR-ANGIOGRAPHY OF CEREBRAL ARTERIOVEN OUS-MALFORMATIONS BEFORE AND AFTER RADIOTHERAPY, Radiologe, 34(8), 1994, pp. 447-453
Citation: Re. Port et al., PHARMACOKINETIC ANALYSIS OF SPARSE IN-VIVO NMR-SPECTROSCOPY DATA USING RELATIVE PARAMETERS AND THE POPULATION APPROACH, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 187-193